The turbulent seas of women's health - Who is the beneficiary?

Maturitas

Volumn 48, Issue 1, 2004, Pages 5-7

  Al Azzawi, Farook ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

BLEEDING; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLON CANCER; DRUG SAFETY; ENDOMETRIUM CANCER; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HEALTH; HEALTH CARE COST; HEALTH INSURANCE; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; INFORMED CONSENT; LOW DRUG DOSE; MASS MEDIUM; MEDICAL LITERATURE; MENOPAUSAL SYNDROME; NOTE; POLITICS; PUBLICATION; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; STROKE; SYMPTOM; THROMBOEMBOLISM;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTHY PEOPLE PROGRAMS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); RANDOMIZED CONTROLLED TRIALS; UNITED STATES; WOMEN'S HEALTH SERVICES;

EID: 3042542592     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2004.03.005     Document Type: Note

References (4)

1. Rossouw J.E., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288(3):2002;321-333
2. Manson J.E., et al. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med. 349(6):2003;523-534
3. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 362(9382):2003;419-427
4. Smith D., et al. Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med. 293:1975;1164-1167